All Stories

UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks

Merck KGaA is in advanced talks to acquire cancer and rare disease specialist SpringWorks, which has a market value of around $3 billion, Reuters reported Monday. Merck KGaA confirmed the talks but said it's not certain a deal will come together.

Feb 11, 2025 - 16:41
 0
UPDATE: Merck KGaA sets its sights on acquisition of Ogsiveo maker SpringWorks
Merck KGaA is in advanced talks to acquire cancer and rare disease specialist SpringWorks, which has a market value of around $3 billion, Reuters reported Monday. Merck KGaA confirmed the talks but said it's not certain a deal will come together.
Read More

Tags:

Previous Article

Mugler Fragrances Taps Cai Xukun as Global Ambassador

Next Article

Greenpeace sues US energy group in test of new EU freedom of speech rules

Related Posts

It’s official: Senate votes to confirm RFK Jr. as HHS secretary

It’s official: Senate votes to confirm RFK Jr. as HHS s...

Feb 13, 2025  0

Lilly banks stockpile of oral GLP-1 drug with potential launch still more than a year away

Lilly banks stockpile of oral GLP-1 drug with potential...

Feb 24, 2025  0

AbbVie scores FDA nod for Pfizer-partnered antibiotic Emblaveo

AbbVie scores FDA nod for Pfizer-partnered antibiotic E...

Feb 10, 2025  0